Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
---|
06/23/2005 | WO2004095061A3 Solid-state beta detector for microfluidic devices |
06/23/2005 | WO2004055026A8 Tetracyclic 3-substituted indoles having serotonin receptor affinity |
06/23/2005 | US20050136498 Using pregnancy-associated plasma protein-A (PAPP-A) as diagnostic indicator of cardiovascular and atherosclerotic disorders |
06/23/2005 | US20050136125 Exposure to oxygen antagonist in vivo; organ transplantation, hyperthermia, wound healing, hemorrhagic shock, cardioplegia for bypass surgery, neurodegeneration, hypothermia, and cancer |
06/23/2005 | US20050136064 Liposomal composition composed of pre-formed liposomes having entrapped therapeutic agent and plurality of targeting conjugates composed of lipid, hydrophilic polymer and targeting ligand; target-cell sensitized liposome composition formed by incubating liposomal composition with selected conjugate |
06/23/2005 | US20050136008 Polybiotin compounds for magnetic resonance imaging and drug delivery |
06/23/2005 | US20050136003 Novel chemical agents comprising a cardiotonic moiety and an imaging moiety and methods of their use |
06/23/2005 | US20050136002 Use of particulate contrast agents in diagnostic imaging for studying physiological paramaters |
06/23/2005 | US20050136001 Fluorinated carbohydrate conjugates |
06/23/2005 | CA2546057A1 Method to improve the efficacy of therapeutic radiolabeled drugs |
06/22/2005 | EP1543025A2 Human g protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure |
06/22/2005 | EP1542734A1 Isotopically labelled indolinone derivatives and process for their preparation |
06/22/2005 | EP0973554B1 Chelating agents |
06/22/2005 | CN1630530A Polyalkylene polymer compounds and uses thereof |
06/21/2005 | US6908903 Cluster clearing agents |
06/21/2005 | US6908598 Rubidlum-82 generator based on sodium nonatitanate support, and improved separation methods for the recovery of strontium-82 from irradiated targets |
06/16/2005 | WO2005054128A2 Method and apparatus for synthesis of [11c] phosgen using concentrated [11c] carbon monoxide with uv light |
06/16/2005 | WO2005053752A2 Novel imaging agents comprising caspase-3 inhibitors |
06/16/2005 | WO2005033652A3 Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol |
06/16/2005 | WO2005023180A3 Method for detecting cancer cells and monitoring cancer therapy |
06/16/2005 | WO2004069159A3 Vitamin receptor binding drug delivery conjugates |
06/16/2005 | WO2003012072A3 Monoclonal antibodies to activated erbb family members and methods of use thereof |
06/16/2005 | US20050131223 Method for preparing radiolabeled thymidine having low chromophoric byproducts |
06/16/2005 | US20050130274 Enzymatic process for the synthesis of organo-fluorine compounds |
06/16/2005 | US20050130167 Multifunctional magnetic nanoparticle probes for intracellular molecular imaging and monitoring |
06/16/2005 | US20050129667 treating leukemia or bone cancer by injecting a samarium comples of ethylenediaminetetramethanephosphonic acid and another chemotherapeutic agent; stem cell/bone marrow transplantation and/or restoration; patient is not subjected to total body irradiation |
06/16/2005 | US20050129619 N2S2 chelate-targeting ligand conjugates |
06/16/2005 | US20050129615 Non-invasive system for detecting skin cancer |
06/16/2005 | US20050129613 Mixing radioactive Technetium ethylenedicystiene complex with N-[2-(1H-pyrrolylmethyl)]-N'-(4-penten-3on-2)-ethane-1,2-diamine, and incubating |
06/16/2005 | US20050129612 competitive binding assays useful in identification of enzyme inhibitors, used for the treatment of neurological disorders such as Alzheimer's disease |
06/16/2005 | US20050129611 Drugs for the diagnosis of tissue reproductive activity or the treatment of proliferative diseases |
06/16/2005 | US20050129610 Imaging agents and methods of imaging alpha7-nicotinic cholinergic receptor |
06/16/2005 | CA2547236A1 Imaging agents comprising caspase-3 inhibitors |
06/15/2005 | EP1539818A2 Compositions and uses thereof for identifying and targeting provasopressin-expressing cancer cells |
06/15/2005 | EP1539252A2 Blood clot-targeted nanoparticles |
06/15/2005 | EP1539250A1 Radioactively labelled amino acid analogues, their preparation and use |
06/15/2005 | EP1539216A2 Labelled somatostatin analogs backbone cyclized through metal complexation |
06/15/2005 | EP1539207A1 Treatment of cell proliferative disorders with chlorotoxin |
06/15/2005 | EP0969866B1 Immunotherapy of b-cell malignancies using anti-cd22 antibodies |
06/15/2005 | CN1628114A Coumarines useful as biomarkers |
06/15/2005 | CN1627962A Non-invasive diagnostic imaging technology for mitochondria using radiolabeled lipophilic salts |
06/14/2005 | US6906050 With various substitutents in the 12- and 17-positions of the porphyrin skeleton; atherosclerosis, restenosis |
06/14/2005 | US6906031 Polyacid glycopeptide derivatives |
06/14/2005 | US6905671 Using isotope of 5-aminolevulinic acid |
06/14/2005 | US6905668 Diagnostic agents for pancreatic exocrine function |
06/09/2005 | WO2005051948A1 Radioactive tropane alkaloid derivative, tropane alkaloid derivative, and process for producing them |
06/09/2005 | WO2005051424A1 Targeting of erb antigens |
06/09/2005 | WO2005051416A1 Pharmaceutical formulations for the sustained release of one or more active principles and applications thereof, such as therapeutic applications |
06/09/2005 | WO2005051315A2 On-demand cleavable linkers for radioconjugates for cancer imaging and therapy |
06/09/2005 | WO2005023177A3 Human monoclonal antibodies against bacillusanthracis protective antigen |
06/09/2005 | WO2005023096A3 Methods and compositions for ultrasound imaging of apoptosis |
06/09/2005 | WO2005016387A3 Dna-dependent mri contrast agents |
06/09/2005 | US20050124844 Combination ionizing radiation and radiosensitizer delivery devices and methods for inhibiting hyperplasia |
06/09/2005 | US20050124549 Method of modulating the proliferation of medullary thyroid carcinoma cells |
06/09/2005 | US20050124005 Use of a labeled ligand having human cd4 specificity for producing a diagnostic used in the analysis of migration and/or distribution patterns of cell populations |
06/09/2005 | US20050123981 Using gastrointestinal specific genes (GSG) as tools in detection of cell proliferative disorders; immunodiagnostics; immunohistochemistry |
06/09/2005 | US20050123552 Anti-(fibronectin binding site) antibodies, peptides and epitopes that give rise to antibodies that block the binding of fibronectin binding proteins to fibronectin |
06/09/2005 | US20050123540 administering synergistic antibodies for treatment of lymphocytic lymphomas and leukemia; immunotherapy |
06/09/2005 | US20050123477 Benzothiazole derivatives for in vivo imaging of amloid plaques |
06/09/2005 | US20050123476 Imaging the activity of extracellular protease in cells using mutant anthrax toxin protective antigens that are cleaved by specific extracellular proteases |
06/09/2005 | US20050123473 Diagnosis, therapy, image of celluloar disorders; antitumor agents |
06/09/2005 | CA2547435A1 Targeting of erb antigens |
06/09/2005 | CA2546675A1 Pharmaceutical formulations for the sustained release of one or more active principles and applications thereof, such as therapeutic applications |
06/08/2005 | EP1536844A2 Preparation of m(co)3-complexes by solid phase techniques via metal assisted cleavage from the solid support |
06/08/2005 | EP1536843A2 Radiolabeled compounds and liposomes and their methods of making and using the same |
06/08/2005 | EP1536818A2 Fibrinogen binding moieties |
06/08/2005 | EP1069919B1 Stimulus sensitive gel comprising a radioisotope and methods of making such gel |
06/07/2005 | US6903070 Mixtures of peptide antibiotics and cyclodextrins used for prophylaxis of bacterial infections in humans |
06/07/2005 | US6902890 Method of diagnosing monitoring, staging, imaging and treating cancer |
06/07/2005 | US6902719 Administering a reverse tracer of labeled glucose, unlabeled lactose to a patient and assessing labeled carbon dioxide in breath or blood; if the lactose is digested, labeled CO2 produced by labeled glucose, diluted by metabolism of lactose |
06/07/2005 | US6902718 Such as methionine and radiolabelled somatostatin receptor-binding peptide depreotide; for increasing shelf-life/storage stability; medical diagnosis |
06/02/2005 | WO2005049096A2 Protein and polymer conjugates as chelants with enhanced blood retention |
06/02/2005 | WO2005049095A2 Contrast agent imaging angiotensin ii receptors |
06/02/2005 | WO2005049005A1 Inhibitor imaging agents |
06/02/2005 | WO2005048822A2 Antibodies and/or conjugates thereof which bind to the amino terminal fragment of urokinase, compositions and uses thereof |
06/02/2005 | WO2005048810A2 Sigma-2 receptor radiotracers for imaging the proliferative status of solid tumors |
06/02/2005 | WO2005026325A3 Bivalent targeting of cell surfaces |
06/02/2005 | WO2004065547A3 Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods |
06/02/2005 | US20050118165 useful for imaging such tumors; scintigraphic detection, diagnosis, prognosis, monitoring and therapy of Met-bearing tumors |
06/02/2005 | US20050118105 Cascade polymer bound complexing compounds, their complexes and conjugates, processes for their production, and pharmaceutical agents containing them |
06/02/2005 | US20050118100 Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent |
06/02/2005 | US20050118099 Thiol-mediated drug attachment to targeting peptides |
06/02/2005 | US20050118098 Radioactive ion |
06/02/2005 | CA2747871A1 Compositions and methods for the treatment of tumor of hematopoietic origin |
06/02/2005 | CA2546237A1 Antibodies and/or conjugates thereof which bind to the amino terminal fragment of urokinase, compositions and uses thereof |
06/02/2005 | CA2545267A1 Inhibitor imaging agents |
06/01/2005 | EP1534391A1 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders |
06/01/2005 | EP1534347A2 Conjugates of n-hydroxypropymethacrylamide-methacrylate copolymer with nuclide activation agent and/or anti-cancer compounds |
06/01/2005 | EP1534332A2 Antibodies and uses thereof |
06/01/2005 | CN1622832A Labeled macrophage scavenger receptor antagonists for imaging atherosclerosis and vulnerable plaque |
06/01/2005 | CN1622830A Peptide-based compounds |
06/01/2005 | CN1622754A Novel immune effect compound |
06/01/2005 | CN1621407A Diphosphonic acid derivative, radioactive 99mTc labeled diphosphonic acid derivative and uses thereof |
06/01/2005 | CN1203899C Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy |
05/31/2005 | US6899864 Kit and method for targeting of a diagnostic or therapeutic agent to target site in mammal having a pathological condition |
05/26/2005 | WO2005046733A1 Contrast agent for medical imaging techniques and usage thereof |
05/26/2005 | WO2005046449A2 Soluble tcr molecules and methods of use |
05/26/2005 | WO2005010048A3 Rg1 antibodies and uses thereof |
05/26/2005 | WO2004100490A3 Device and method for the fluorination of nucleophiles |
05/26/2005 | WO2004093652A3 System and method for synthesis of molecular imaging probes including fdg |